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ABSTRACT
The treatment of cardiovascular disease (CVD) is managed 
inadequately globally. Theoretically informed frameworks 
have the potential to account for the multiple elements 
which constitute the CVD patient pathway, and capture 
their inter- relationships and processes of change. However, 
a review and critique of such frameworks is currently 
lacking. This systematic review aims to identify and 
critically assess frameworks of access to and utilisation 
of care which capture the pathways of patients diagnosed 
with one or more CVDs. The specific objectives are to (1) 
review how existing frameworks have been used and 
adapted to capture CVD patient pathways and (2) draw 
on elements of Strong Structuration Theory to critically 
appraise them, in terms of their ability to capture the 
dynamics of the patient journey and the factors that 
influence it. Five bibliographic databases were searched 
in January 2019. We included qualitative and quantitative 
studies containing frameworks used to capture the patient 
pathway of individuals with CVD, encompassing symptoms, 
diagnosis, treatment and long- term management. Data on 
patient behaviour and structural factors were interpreted 
according to elements of Strong Structuration Theory to 
assess frameworks on their ability to capture a holistic 
patient journey. The search yielded 15 articles. The majority 
were quantitative and all focused on management of 
CVDs, primarily hypertension. Commonly used frameworks 
included the common- sense self- regulation model, 
transtheoretical model and theory of planned behaviour. 
A critique drawing on elements of Strong Structuration 
Theory revealed these frameworks narrowly focused on 
patient attributes (patient beliefs/attitudes) and resulting 
patient action, but neglected external structures that 
interacted with these to produce particular outcomes, 
which results in an individualistic and linear view of the 
patient pathway. We suggest that a framework informed 
by Strong Structuration Theory is sufficiently flexible to 
examine the patient pathway, while avoiding a strict linear 
view facilitated by other frameworks.
INTRODUCTION
Cardiovascular disease (CVD) continues 
to be managed inadequately in countries 
at all levels of development.1 Many indi-
viduals diagnosed with CVD face barriers 
accessing affordable, high- quality, long- 
term care, and even if they overcome 
them, a high proportion soon fail to 
adhere to treatment. The reasons relate 
to the design of health systems, the health 
services that are provided, their respon-
siveness to patient needs and expecta-
tions and characteristics of the patients 
themselves. Many of these factors have 
been addressed in isolation, with limited 
success. As a consequence, attention is 
moving towards a holistic approach taking 
into account individual, institutional and 
structural factors and how these interre-
late to shape patient pathways.2 This is the 
approach taken by the ‘Responsive and 
Equitable Health Systems—Partnership on 
Non- communicable Diseases’ (RESPOND) 
study, which aims to holistically explore 
pathways of hypertensive patients in 
Malaysia and the Philippines.3 Achieving 
Key questions
What is already known?
 ► Several theoretical frameworks have been used to 
understand the complex behaviours and care path-
ways of patients with cardiovascular disease (CVD).
What are the new findings?
 ► These existing frameworks are insufficient to fully 
grasp the nuances that characterise CVD patient 
behaviour and the factors which shape their actions 
over time.
What do the new findings imply?
 ► A framework drawing on elements from Strong 
Structuration Theory may provide the flexibility and 
comprehensiveness needed to overcome these 
deficits.
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this aim requires a critical analysis of existing frame-
works which attempt to capture pathways of patients 
diagnosed with CVDs.
Patients with CVDs frequently come in and out of 
what are considered ideal or ‘standardised’ pathways. 
For instance, patients may discontinue medication, 
disengage with health services and/or develop alterna-
tive management to the ones planned by health services 
(eg, consume traditional medicine). Frameworks are 
beneficial insofar as they can illuminate a snapshot 
of the multiple elements (individual, sociocultural or 
health system- related) which constitute the pathway, and 
capture their inter- relationships and processes of change. 
Second, frameworks may be derived from theories which 
provide explanation of the observed phenomena. As 
such, they may represent an operationalisation of a set 
of ideas or theory. Frameworks also enable the explora-
tion of patterns across multiple settings (within or across 
countries) and of underlying common patterns and 
obstacles along the pathway.
A range of theoretical frameworks have been devel-
oped to facilitate understanding of patient pathways,4 
offering a broad picture of the multiple elements 
(individual or health system- related) which constitute 
the pathway. Theoretical frameworks have improved 
understanding of relationships between health beliefs 
and medication- taking behaviour.5 Treatment- adherent 
patients may be highly engaged with the health system, 
accessing professional help when needed, responding 
to professionals when contacted and closely following a 
set care plan. Meanwhile, poorly adhering patients may 
be less engaged or engage at different points than their 
adherent counterparts; although, in reality, the same 
patients may fall into both categories at different times, 
as circumstances within the health system, their personal 
life, family resources and logistic factors such as avail-
ability of transportation change.
A patient pathway is a construct that explains success 
or failure in patients’ progression through a planned 
health trajectory. When frameworks describing these 
pathways are too narrow (eg, focusing only on personal 
or biomedical aspects), they remove attention from 
broader sociostructural dimensions of health experi-
ences and engagement with care,6 constructing patients 
as ‘the problem’. As such, frameworks imply presupposi-
tions of who/what the problem is and produce particular 
representations of patients. A critical appraisal of existing 
frameworks focused on CVD patient pathways is neces-
sary to illuminate such presuppositions and develop 
frameworks which facilitate a more holistic account of 
patient behaviour and social circumstances which may 
shape behaviour.
This paper presents the findings of a systematic review 
seeking to identify and critically assess frameworks of 
access to and utilisation of care which capture the path-
ways of patients diagnosed with one or more CVDs. 
The specific objectives are to (1) review how existing 
frameworks have been used and adapted to capture 
pathways followed by patients with CVD and (2) draw on 
elements of Strong Structuration Theory (SST) to crit-
ically appraise them, in terms of their ability to capture 
the dynamics of the patient journey and the factors that 
influence it. In the ‘Theoretical background’ section, we 
provide a description of the key elements of SST, starting 
by outlining Structuration Theory, its predecessor.
Theoretical background
Sociological perspectives are useful for exploring the 
dynamic processes and mechanisms which mediate 
patient engagement with health systems, including 
barriers encountered.7 8 For instance, Structuration 
Theory, developed by Giddens in ‘The Constitution of 
Society’,9 focuses on micro- level, meso- level and macro- 
level factors to explain individual behaviour and features 
of society, and crucially, how these evolve over time.
Structuration Theory attempts to overcome two 
opposing approaches in the social sciences: the struc-
turalist approach, which tends to overlook the poten-
tial of human action, and the individualistic approach, 
which tends to neglect the impact of social structures in 
shaping action.9 10 Giddens attempted to integrate these 
approaches. He defined structures as rules (procedures 
which perpetuate social life, including social conven-
tions and official regulations) and resources (sources of 
power).9 Agency is human action, and involves individ-
uals being knowledgeable about the rules or conventions 
that govern this action. Critically, Giddens proposed a 
‘duality of structure’: that structures are created by, and 
shape, human agency.11 Thus, structures and agency are 
interdependent and mutually reinforcing, two sides of 
the same coin. This approach has enabled researchers to 
explore social phenomena at macrolevel mesolevel and 
microlevel.12
Structuration Theory does, however, have an important 
limitation in that empirical researchers have struggled to 
operationalise these concepts of structure and agency. 
Archer argued that structure and agency cannot be sepa-
rated empirically in Giddens’s version of Structuration 
Theory, precluding the possibility of studying the inde-
pendent properties of either.13 In a similar vein, Stones 
criticises Structuration Theory on the grounds that it 
treats agency and structure as abstract concepts only, 
limiting empirical application.11
Progressing from these debates, Stones revised Structur-
ation Theory and offered a tighter and clearer synopsis of 
the theory in order to guide empirical research, termed 
SST.11 The theory consists of four main elements (a ‘quad-
ripartite cycle of structuration’) consisting of external 
structures, internal structures, action/active agency and 
outcomes.11 The elements are illustrated in figure 1.
External structures are autonomous to individuals, 
and include traditions, norms, moral codes and estab-
lished ways of doing things. They include macro- level 
societal institutions such as health, legal and educational 
systems. Although these factors and institutions shape 
human behaviour (and human choice), this relationship 
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is bi- directional; external structures are modified by the 
choices made by individuals.11 For instance, patients 
choosing to treat their hypertension with complimentary 
medicine perpetuates this industry. External social struc-
tures become internalised into individuals’ views of the 
social world, forming internal structures. Internal struc-
tures consist of two types: (i) general dispositions are the 
relatively enduring and transposable attitudes, opinions, 
beliefs and embodied knowledge of socially positioned 
individuals (similar to Bourdieu’s notion of habitus);14 
this is the generalised knowledge of, and set of dispositions 
towards, the world, which individuals adapt to different 
situations; and these defining characteristics include the 
interpretative (or cultural/phenomenological) frames 
that inform their practices across conjunctures and situ-
ations; and (ii) conjuncturally specific internal structures 
comprises situationally specific knowledge concerning 
aspects of the immediate terrain of action; this kind of 
knowledge, which is always framed by the cultural frames 
of general dispositions, is often significantly altered by 
involvement in, and experience of, social practices within 
specific terrains, which themselves are typically in flux. 
The third element of SST is action/active agency, exer-
cised by individuals drawing on their internal structures 
in order to act. Such actions produce outcomes, the 
fourth element of SST, either by preserving and repro-
ducing structures faithfully, or changing them depending 
on the behaviour of the individual.11 15
The quadripartite cycle of structuration offers a vantage 
point from which to understand and interpret the non- 
linearity of patient pathways. CVD patients’ experiences 
with initial diagnosis and treatment, and their subse-
quent interaction with the health system could influ-
ence how the patient perceives ‘Western’ or alternative 
forms of treatment. Because SST proposes that internal 
structures are grounded in objective external structures, 
it provides the potential to better comprehend patient 
pathways and choices which are often misaligned with 
ideal or ‘standardised’ pathways. Due to this advantage 
presented by SST, we chose to draw on SST elements to 
critically appraise the articles included in this review.
METHODS
Eligibility criteria
This review focuses on frameworks which have been 
developed and used to capture elements of the patient 
pathway (including symptoms, diagnosis, treatment 
commencement and long- term management) of indi-
viduals with one or more CVDs. No review protocol was 
developed prior to this work. The main inclusion criteria 
included papers which:
 ► featured frameworks with a longitudinal design 
(examined either prospectively or retrospectively), 
examining at least two junctures on the CVD patient 
pathway, from symptoms, diagnosis, treatment initia-
tion and management (while this description of the 
pathway is linear, we recognise it is more complex);
 ► focused on management, but consider steps taken 
over time rather than at one point in time;
 ► featured unique frameworks empirically tested in 
studies of CVDs;
 ► significantly modified or updated an older framework;
 ► inductively proposed a new framework or combined 
elements from two or more frameworks arriving at 
significantly different theoretical models. This crite-
rion, and the criterion bulleted above, yielded the full 
breadth of frameworks that had been used to illus-
trate CVD pathways, rather than an exhaustive compi-
lation of papers using any framework. A set of articles 
containing such a compilation would have been too 
numerous to feasibly synthesise and was beyond the 
core aim of the paper.
The main exclusion criteria excluded papers which:
 ► drew on an existing framework without modifying it;
 ► presented frameworks but not fully describing their 
application in studies, or described framework compo-
nents but neglected to describe interrelationships;
 ► described an intervention;
 ► presented frameworks which described service 
delivery or clinical pathways without capturing patient 
responses;
 ► described structural frameworks used in large- scale 
reform plans and service transformations;
 ► focused on acute or semi- acute CVDs, for instance, 
hypertensive conditions during pregnancy;
 ► were books, editorials, commentaries, poster pres-
entations and protocol papers;
 ► were published in languages other than English.
Search strategy
We followed an iterative process, progressively refining 
our focus and search strategy, drawing on the multidis-
ciplinary nature of our team to incorporate a range of 
expertise to direct the search strategy.16 This organic 
Figure 1 Elements of Strong Structuration Theory. Adapted 
from Stones.11
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process was appropriate for the exploratory nature of the 
review.
A preliminary search on Medline was conducted in 
June 2017, updated and broadened in a final database 
search conducted in January 2019, which also included 
PsychINFO, International Bibliography of the Social 
Sciences, Academic Search Complete and Web of Science 
databases. A full Medline search string is provided in the 
online supplementary material.
Filters were used to select English- language articles 
only, and to exclude articles published before 1980. 
Search terms covered aspects related to: CVDs (including 
heart failure, hypertension, heart disease and angina), 
quantitative and qualitative empirical studies, patient 
pathways and conceptual frameworks.
Selection process
Selection of papers for inclusion followed the five stages 
in the preferred reporting items for systematic reviews 
and meta- analysis checklist.17 First, titles and abstracts 
identified in the initial Medline search as outlined above 
were downloaded into Endnote. Second, these were 
independently reviewed by two authors against the inclu-
sion and exclusion criteria. Titles and abstracts identified 
in the final search in January 2019 were independently 
screened by two authors, and full texts screened by three 
authors. Full texts of articles were screened by MLS, 
AR and DB. Articles that fulfilled the inclusion criteria 
outlined above were included in the review. Disagree-
ments were resolved by discussion within the research 
team. An in- depth review of included studies was 
conducted. As our review is focused on frameworks used 
in articles, rather than the robustness of studies them-
selves, quality of included articles was not assessed.
Data extraction and analytic approach
Article aim, type of CVD, country of study (and classifica-
tion of country by income status), setting, sample, meth-
odology and elements of pathways captured (symptoms, 
diagnosis, treatment initiation and/or managements) were 
extracted from each article into an Excel spreadsheet. The 
specific framework(s) drawn on or created were identified 
and extracted, as well as details on how existing frameworks 
were modified. We also recorded whether the framework 
was used for deductive purposes (eg, to classify and inter-
pret findings) or in an inductive way (eg, as emerging from 
the themes observed in findings).
The frameworks included in the articles were exam-
ined to assess the extent to which they captured aspects 
of patient behaviour and the structural factors impacting 
the patient pathway. The most commonly used frame-
works were contextualised by tracing the origin of the 
framework, along with its key elements and critiques. At 
the final stage, data on patient behaviour and structural 
factors presented in the papers were interpreted and 
coded according to elements of Stones’ SST.11 Specifically, 
instances of agency, internal and external structures, and 
the impact of agency on structures and vice versa were 
extracted where reported.
Patient and public involvement
Representatives for neither patients nor the public were 
involved in developing this paper. However, they were 
extensively involved in the wider study,3 which prompted 
this review.
RESULTS
Study selection
The results from the search are shown in figure 2. A total 
of 2179 records were identified at stage 1. After duplicates 
(n=124) were removed, titles and abstracts of 2055 were 
screened, yielding 219 full texts. This high number of full 
texts relative to the number of records initially identified 
reflects the challenge facing the research team as they 
sought to determine whether an innovative framework 
was used or developed in articles, which was frequently 
difficult to ascertain from abstracts and titles alone. 
A total of 204 were excluded due to lack of innovative 
framework, article type (notably interventions studies) 
and/or lack of empirical application of the framework. 
This left 15 for our review.
Details of the 15 included studies are reported in table 1. 
Although our scope was global, they were overwhelmingly 
from high- income countries. Nine were quantitative,18–26 
four qualitative27–30 and two used mixed methods.31 32 
Figure 2 Results of the screening process. CVD, 
cardiovascular disease.
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Six focused on hypertension,19–21 24 28 29 three each on 
heart failure26 27 31 and coronary heart disease18 23 25 and 
there was one study each on congestive heart failure,30 
acute coronary syndrome22 and myocardial infarction.32 
Although we hoped to cover all parts of the CVD patient 
pathway, spanning symptoms, diagnosis, treatment initi-
ation and long- term maintenance (including treatment 
adherence), the studies focused exclusively on long- term 
management.
Frameworks to capture CVD patient pathways
Of the 15 included studies, 3 proposed a new framework, 
10 drew on and modified existing frameworks and 2 used 
a combination of these approaches. The common- sense 
self- regulation model (and earlier self- regulation model) 
were the most commonly used, with five studies using 
them deductively.18 19 23 25 30 Three studies drew on the 
theory of planned behaviour22 25 or the earlier theory of 
reasoned action21 on which it is based. All of these studies 
incorporated elements of these theories with other 
existing frameworks.
Eight studies adopted a deductive approach and 
modified existing frameworks, including the health 
decision model,20 health belief model,21 theoretical 
domains framework32 or other models.22 23 26 31 32 Three 
studies proposed altogether new frameworks, following 
an inductive process.24 27 28 Additional details on these 
models appear in table 1.
As the common- sense self- regulation model, theory of 
planned behaviour and the transtheoretical model were 
the most commonly applied frameworks in our included 
articles, we next present an overview of key elements as 
originally developed in the three sections below entitled 
common- sense self- regulation model, theory of planned 
behaviour, and transtheoretical model. We show how 
each has two important limitations in conceptualising 
CVD patient pathways, so we seek an alternative. We show 
how Structuration Theory addresses some of the main 
limitations and discuss how it represents an advancement 
over the current types of framing.
Common-sense self-regulation model
The self- regulatory model, more recently known as the 
common- sense self- regulation model is a widely used 
theoretical framework for examining perceptual, behav-
ioural and cognitive processes at play in self- management 
of health threats.33 34 It postulates that an individual’s 
perception of illness (termed cognitive representa-
tions) motivates the degree to which they take action 
to improve their health status.35 36 The original frame-
work viewed individual perceptions of illness as resulting 
from five factors: illness identity (label or disease name 
and perceptions of associated symptoms), their causes 
(factors and/or behaviours predisposing an individual 
to the condition), consequences (personal impact of the 
condition, including experienced and anticipated phys-
ical, cognitive and social disruption), control (behaviours 
to regulate the condition) and timeline of the illness S
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(individual perceptions about the duration of illness; 
chronological aspects of the disease course and manage-
ment).33 35–37 More recent iterations of the framework 
separated the control factor into treatment control and 
personal control.
Proponents of the common- sense self- regulation 
model argue that the framework offers insights into 
individual differences in how illnesses are perceived, 
and how this influences behaviour regarding the 
illness.23 However, it has been criticised for the relative 
lack of attention to environmental and social factors in 
explaining patient behaviours.38 Moreover, it does not 
cover beliefs about medication or treatment, and how 
these may influence adherence.39 The authors acknowl-
edge that the framework requires additional modifica-
tion to fully grasp the dynamic nature of cognition and 
patient behaviour over time.40 For instance, Leventhal 
et al33 note:
The [common- sense self- regulation mode] is […] struc-
tured to describe transitions in behavior, that is, from 
nonadherence to adherence and from adherence to non- 
adherence, though few investigators have addressed the 
details of transitional processes. […] We need to identify 
and assess the variables and dynamic process involved in 
the initial transitions from discovering symptoms and label-
ing oneself as ill, to the intermediate term for seeking care 
and initiating treatment, to the transition from initiation to 
habitual performance of behaviors that is locked into daily 
behavioral patterns (pp. 936 and 944).
Theory of planned behaviour
The theory of planned behaviour, developed from 
the earlier theory of reasoned action41 seeks to predict 
and explain human behaviour in specific contexts.42 
According to the former, health- related behaviour is 
a function of an individual’s intention to perform the 
action in question (termed behavioural intention).42 
Intention results from three constructs: positive or nega-
tive attitude towards the action, perception of the social 
support or opposition to their fulfilling the action and 
individual perceptions of control over resources such as 
skills, confidence, and the ability to perform the behav-
iour. These elements influence an individual’s intentions, 
which then predict behaviour.
Critics have pointed out that the theory of planed 
behaviour is insufficient for predicting behaviour, as 
intentions can change during the period between 
the measurement of intention and the behaviour of 
interest.43 Thus, an intended behaviour may not be 
carried out. Some have suggested that forming action 
plans can bridge the intention- behaviour gap.44 Others 
have argued that factors beyond intention may influence 
behaviour, such as past behaviour, habits, self- identity 
and personality.45 46 A co- developer of the theory of 
planned behaviour emphasises that it should be modified 
if factors influencing intention beyond the original three 
constructs are identified.42
Transtheoretical model
The transtheoretical model of behavioural change, or 
the stages of change model, was proposed by Prochaska 
and DiClemente.47 Originally focusing on cessation of 
tobacco use, they suggested that behaviour change occurs 
in discrete stages: precontemplation (not thinking about 
stopping), contemplation (planning to stop between 31 
days and 6 months in the future), preparation (plan-
ning to stop within 30 days), action (having stopped 
for 0–6 months) and maintenance (having stopped for 
>6 months).47 Another iteration included a sixth stage 
of change, termination (individual has permanently 
stopped).48 In all stages, individual self- efficacy is neces-
sary to implement the behaviour change.48
Proponents of the transtheoretical model argue the 
model has enhanced health promotion interventions 
by highlighting the need to tailor interventions (beyond 
smoking cessation) according to the particular stage at 
which target individuals are situated, thereby improving 
effectiveness.48–50 Critics have argued that the time periods 
defining the stages are arbitrary,51 that the model unjusti-
fiably assumes that individuals make coherent and stable 
plans52 and that important factors in behaviours change 
(such as reward and punishment) are unacknowledged.53 
Nonetheless, authors have used constructs of the trans-
theoretical model to complement self- regulatory models 
(including the common- sense self- regulation model), 
arguing that this adds predictive value23 and enables a 
delineation between initial versus long- term behaviour 
change.54
Critique of current frameworks
The common- sense self- regulation model, transtheo-
retical model, theory of planned behaviour and theory 
of reasoned action share many common elements: all 
focus on the role of individual attitudes, perceptions 
and intention on subsequent individual behaviour,4 
resulting in a representation of individual patient attrib-
utes as sole driving factors of pathways that depart from 
clinical guidelines. The impact of features of the health 
system (such as access, quality, patient- practitioner rela-
tions, health system department relations, etc) on medi-
cation adherence are beyond the explanatory scope of 
such frameworks. As a corollary, none of the frameworks 
above focus on how attitudes, intentions and percep-
tions are developed in the first place; they are treated as 
already- existing entities independent of the social world, 
including social, political, economic factors. It is increas-
ingly recognised that individual behaviour is rooted in 
formal and informal structures, values and beliefs, and 
a focus solely on individuals obscures these influences.55
Efforts to integrate key elements from prominent theo-
ries of health behaviour have sought to address these 
issues, by inclusion of elements such as ‘environmental 
constraints’ (encompassing factors in the social environ-
ment) into explanatory models of health behaviour.56 
However, even efforts to widen the group of variables (to 
include the social context) fail to address a fundamental 
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issue: each framework takes an exclusively linear explan-
atory view of patient behaviour. Patient behaviour is 
taken as an end point to be explained, with independent 
factors including attitudes, preconceptions and inten-
tions driving the behaviour of the patient as they progress 
towards that point. While patient behaviour and associ-
ated outcomes may be explained to some extent by these 
factors, patient behaviour is never static; patients may 
move between periods of adherence and non- adherence. 
The models do not articulate the ongoing consequences 
of these behaviours over time.
Given the limitations of existing frameworks, we have 
looked towards SST as it extends beyond individual- 
level explanations of patient behaviour (including the 
mesolevel and macrolevel), while recognising the non- 
linear nature of the pathways followed.
Application of Strong Structuration Theory concepts to 
included articles
To explore the potential of SST to capture CVD patient 
pathways, we test the usefulness of the theory through 
applying its elements (external and internal structures, 
instances of patient agency and outcome) to the findings 
of the included articles (see online supplementary mate-
rial, table 2). Articles are assessed according to the focus 
on agency, structure or both, and whether they propose a 
continuous (perpetual, never- ending) view on the patient 
pathway or a static view featuring an end- point cut- off. 
Seven articles focused primarily on structure,18 20–25 six 
on both agency and structure19 27–30 32 and two on agency 
exclusively.26 31 The frameworks in included articles over-
whelmingly take a static approach to the patient pathway, 
with only one article adopting a continuous viewpoint.30
Articles considered the role of external structures 
including the healthcare system,19 20 27 29 30 social welfare 
system, work,21 28 physical environments,28 29 insurance 
companies,21 30 support system of family/friends,30 32 
community educational resources on CVDs,29 social stigma 
against medication,31 societal patriarchal attitudes,21 29 
social isolation28 and poverty.18 This wide array of struc-
tures indicates the healthcare system consists of (and is 
linked with) many kinds of external structures. Those 
structures beyond the healthcare system (eg, phys-
ical environments and patriarchal attitudes) are also 
potentially important factors in understanding patient 
behaviour and pathways.
Of the four SST elements, internal structures received 
the most attention, with all but two articles19 26 covering 
patient attitudes and beliefs. Eleven included patient atti-
tudes toward treatment (including medication, diet and 
exercise regimes),18 20–24 28–32 with specific attention on 
attitudes towards food,29 prognosis29 30 and symptoms.30 
Beliefs about the causes28 30 and nature of CVDs (specif-
ically hypertension18 20 28 and coronary heart disease25) 
also featured prominently in the articles, along with 
attitudes towards health providers.20 27 30 32 Patient atti-
tudes towards themselves were also explored, covering 
patient self- esteem,27 29 self- efficacy,23 29 32 confidence21 
and self- identity.24 32 Finally, articles captured patient atti-
tudes towards societal gender roles29 and stigma,31 as well 
as the role of religious beliefs29 on management. Despite 
the inclusion of these internal structures in articles, there 
was a relative lack of exploration of how they are influ-
enced and formed by external structures.
In contrast, links between these internal structures 
and subsequent patient actions were explicit, with a wide 
variety of behaviours reported against the backdrop of 
these attitudes and beliefs. Most patient actions were 
framed as attempts to manage CVDs18–20 23 26 27 29 31 by 
making plans to control their condition27 32 on the basis 
of various forms of specific situational knowledge, such as 
monitoring symptoms,26 using medication reminders to 
develop a routine,32 addressing lifestyle risk factors,23 28 29 
joining workplace heath programmes,21 seeking infor-
mation on their condition and treatment27 and seeking 
advice and support.29 Some patients unilaterally chose to 
alter their hypertension medication on the basis of blood 
pressure readings,28 others declined medication29–31 or 
exercise regimes.25 One article reported that patients 
chose to present for care at emergency rooms rather than 
primary care.30
Of the four core concepts of SST, outcomes were 
focused on the least. Only one article touched on the 
impact of patient actions on structures, in this case 
external structures, by linking the tendency of patients 
to present at emergency rooms as perpetuating the treat-
ment of congestive heart failure in hospitals rather than 
primary care.30
DISCUSSION
Conceptual frameworks can provide a tool that helps to 
make sense of the complex reality of CVD patient path-
ways, assisting in identifying the multiple interacting 
factors shaping it. This review draws on elements of SST 
to critically appraise existing CVD patient pathway frame-
works, in terms of their ability to capture the dynamics 
of the patient journey and the factors that influence it. 
Despite the importance of models to understand rela-
tionships between health beliefs and medication- taking 
behaviour,5 we found relatively few papers that provided 
ones that capture the pathways followed by patients with 
CVD, spanning symptoms, diagnosis, treatment and 
long- term management. Moreover, the papers identified 
focused exclusively on the long- term management phase, 
completely excluding any consideration of earlier phases 
of the CVD pathway. The stage at which patients ‘enter’ 
the pathway is absent in the literature, although it is likely 
that a patient’s situationally specific experiences during 
initial symptoms, diagnosis and treatment initiation are 
likely to have an important and lasting impact on how 
they approach long- term maintenance.
An SST- informed framework has the advantage of 
allowing one to conceive of the patient pathway as a 
continuous process, considering how individual patient 
behaviour is shaped by their internalisation of external 
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structures. Such an integrated vantage point is neces-
sary to fully explicate the CVD patient pathway, which 
is typically marked by periods of adherence and non- 
adherence, characterised by shifting structures. Indi-
viduals increasingly access sources of information 
challenging Western medicine, including ideas coming 
from traditional medicine or unorthodox treatment for 
chronic conditions, making treatment choices in situa-
tions of increased complexity and decreased certainty.57 
Factors influencing patient behaviours are not static.
A second advantage is the potential for SST to be used 
flexibly, including facilitating focus on earlier points in 
the patient pathway (eg, initial diagnosis). External struc-
tures relevant to the diagnosis phase may differ from 
later phases; SST facilitates exploration into transitions 
across these phases, allowing a view of patient involve-
ment with healthcare systems as a sequential process 
rather than a one- off event.58 This is a major advance 
over the frameworks identified in this review, which over-
whelmingly focus only on long- term management. With 
these advantages in mind, we suggest that future work on 
CVD patient pathways could benefit by drawing on SST 
elements.
An SST- informed framing allows for an exploration of 
pathways that starts with the patients and their engage-
ment with structures and actors, demonstrating how a 
patient- centred approach can inform health systems 
development. Rather than suggesting a framework with 
a set number of elements and hierarchical relationships, 
we suggest a broad framing that can be useful for future 
work focused on CVD patient pathways which incorpo-
rates these elements and captures the health systems and 
broader structural issues affecting patient progression 
to a successful outcome. We propose an open- ended 
approach that builds on SST principles, offering a flexible 
lens through which to examine the intersecting factors 
affecting patient trajectory. Importantly, the proposed 
conceptual approach, with its flexibility and reconcilia-
tion of multiple influences on the patient journey, can 
help to arrive at context- specific and pragmatic policy 
solutions. These will posit the patient not just as a recip-
ient of care but as a co- creator of health systems.59
The current heavy focus on the influence of indi-
vidual patient beliefs and attitudes on action facilitated 
by current frameworks construct patients as rational (or 
non- rational) decision- makers, with little consideration 
of the factors which shape these beliefs and attitudes in 
the first place. However, in line with previous critiques 
of health psychology approaches typically used in public 
health,60 these external factors do constrain and enable 
patient behaviour, regardless of how rational or well- 
informed patients are. The current type of individual- 
level focus can result in strategies that focus exclusively on 
changing patients’ attitudes, knowledge and behaviour,61 
rather than the environmental (social and health system- 
related) factors which may influence behaviour. To 
better reflect this lived patient reality, future interven-
tion development to modify patient pathways to reflect 
clinical guidelines may benefit from patient involvement 
in co- designing pathways.59
This review has certain limitations. It focused only on 
academic articles published in English. The wide array 
of frameworks in the included articles made compari-
sons difficult. We reviewed 219 full texts, which is high 
relative to other systematic literature reviews. This is due 
to the nuanced nature of the topic which necessitated a 
manual approach to determine the presence or absence 
of appropriate frameworks.
CONCLUSION
Existing frameworks used to understand pathways 
followed by patients with cardiovascular disease are insuf-
ficient to fully grasp the nuances that characterise patient 
behaviour and the factors which shape their actions over 
time. We propose that a framework drawing on elements 
from SST may overcome these deficits. The RESPOND 
study3 is doing this by applying SST concepts to examine 
hypertensive patient pathways in Malaysia and the Phil-
ippines.
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